Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophilsin vitro
- 1 March 1992
- journal article
- inflammation and-immunomodulation
- Published by Springer Nature in Inflammation Research
- Vol. 35 (3-4) , 227-231
- https://doi.org/10.1007/bf01997504
Abstract
Interleukin-8 (IL-8), is a potent activator of polymorphonuclear leukocyte (PMN) functions including chemotaxis, superoxide anion production, and enzyme release and it is also chemotactic for lymphocytes. Additionally, it has recently been shown that IL-8 stimulates the formation of 5-lipoxygenase (LO) products of arachidonic acid (AA) by human PMNs. The purpose of the present study was to determine whether IL-8 also might affect the formation of 15-LO products from AA. Purified PMNs in phosphate buffered saline were preincubated with and without exogenous AA (10−5–10−4M) for 10 min. Then IL-8 was added in biologically relevant concentrations ranging from 0.1 to 100 ng/ml and incubation was carried out for 5 min at 37°C. Lipids were then extracted from supernatants, and eicosanoids were determined by quantitative RP-HPLC. Compared with unstimulated cells, IL-8 resulted in a dose dependent increase in both LTB4 and 15-HETE (up to 125% and 40% at 100 ng/ml, respectively). This increase in eicosanoid formation required the presence of exogenous AA. These results indicate that IL-8 is both a potent stimulator of 5-LO activity and of 15-LO activity. LTB4 can induce both inflammation and contribute to hyperproliferation in the skin. 15-HETE in contrast has the ability to inhibit the effects induced by LTB4. Because IL-8 is able to stimulate both LTB4 and 15-HETE formation, the effect of IL-8 as a putative regulator of inflammatory processes may be dependent on the relative stimulation of 5-LO and 15-LO.Keywords
This publication has 34 references indexed in Scilit:
- Receptor-operated activation of polymorphonuclear leukocytes: Different effects of NAP-1IL-8 and fMet-Leu-Phe or C5aBiochemical and Biophysical Research Communications, 1991
- The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.The Journal of Experimental Medicine, 1989
- Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE)Journal of the American Academy of Dermatology, 1988
- 15-Hydroxyeicosatetraenoic Acid (15-HETE) Specifically Inhibits LTB4-Induced Chemotaxis of Human NeutrophilsSkin Pharmacology and Physiology, 1988
- Methotrexate Inhibits the Human C5a-Induced Skin Response in Patients With PsoriasisJournal of Investigative Dermatology, 1987
- Identification of C5ades arg and an Anionic Neutrophil-Activating Peptide (ANAP) in Psoriatic ScalesJournal of Investigative Dermatology, 1986
- Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4British Journal of Dermatology, 1986
- Cutaneous Responses to 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid (12-HETE)Journal of Investigative Dermatology, 1985
- Structural identification of platelet activating factor in psoriatic scaleBiochemical and Biophysical Research Communications, 1985
- Nonsteroidal anti-inflammatory drugs stimulate 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytesJournal of Allergy and Clinical Immunology, 1984